Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 19 - 20: Difference between revisions
From GxPlex
imported>GxPlexBot Import from GxPlex Excel |
gxplex>GxPlexBot Import from GxPlex Excel |
(No difference)
| |
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 1 — Unit 1.5.4 |
| Scope | HM |
| Document part | Article 19 - 20 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Regulatory submission, Advanced-therapy IMP, Clinical trial, Medicinal product |
| Comment | Authorisation procedure for gene therapy medicinal products |
Content
Authorisation procedure for clinical trials involving medicinal products for gene therapy etc. […] Authorisation procedure for clinical trials involving medicinal products with special characteristics [...]
